Immunodeficiency Stocks List

Related ETFs - A few ETFs which own one or more of the above listed Immunodeficiency stocks.

Immunodeficiency Stocks Recent News

Date Stock Title
May 3 VIR Q1 2024 Vir Biotechnology Inc Earnings Call
May 3 GILD The Zacks Analyst Blog Highlights Gilead Sciences, GSK, Deciphera, Bristol Myers and Editas Medicine
May 3 VIR Vir Biotechnology Inc (VIR) (Q1 2024) Earnings Call Transcript Highlights: Navigating ...
May 3 VIR Vir Biotechnology, Inc. (VIR) Q1 2024 Earnings Call Transcript
May 3 BMY Bristol-Myers Squibb: A Lost Decade?
May 2 VIR Vir Biotechnology, Inc. (VIR) Reports Q1 Loss, Tops Revenue Estimates
May 2 SGMO Cardiff Oncology (CRDF) Reports Q1 Loss, Tops Revenue Estimates
May 2 VIR Vir Biotechnology GAAP EPS of -$0.48 beats by $0.59, revenue of $56.38M beats by $44.67M
May 2 SGMO Sangamo Therapeutics Announces First Quarter 2024 Conference Call and Webcast
May 2 VIR Vir Biotechnology Provides Corporate Update and Reports First Quarter 2024 Financial Results
May 2 BMY Schrodinger gets rights to cancer drug candidate back from Bristol
May 2 BMY Biotech Stock Roundup: GILD's GSK' Q1 Earnings, DCPH Soars on Acquisition News & More
May 2 GILD Biotech Stock Roundup: GILD's GSK' Q1 Earnings, DCPH Soars on Acquisition News & More
May 1 VIR Vir Biotechnology Q1 2024 Earnings Preview
May 1 BMY Editas, Bristol Myers extend T cell therapy collaboration
May 1 INO INOVIO Reports Inducement Grants Under Inducement Plan
May 1 BMY Editas Medicine and Bristol Myers Squibb Extend Alpha-Beta T Cell Collaboration
Apr 30 VIR Vir Biotechnology to Participate in the BofA Securities Healthcare Conference 2024
Apr 30 GILD Gilead Sciences, Inc. (NASDAQ:GILD) Q1 2024 Earnings Call Transcript
Apr 30 BMY Bristol-Myers Squibb Company (NYSE:BMY) Q1 2024 Earnings Call Transcript
Immunodeficiency

Immunodeficiency, also known as immunocompromisation, is a state in which the immune system's ability to fight infectious diseases and cancer is compromised or entirely absent. Most cases are acquired ("secondary") due to extrinsic factors that affect the patient's immune system. Examples of these extrinsic factors include HIV infection and environmental factors, such as nutrition.
Immunocompromisation may also be due to genetic diseases/flaws. An example here is SCID.
In clinical settings, immunosuppression by some drugs, such as steroids, can either be an adverse effect or the intended purpose of the treatment. Examples of such use is in organ transplant surgery as an anti-rejection measure and in patients suffering from an overactive immune system, as in autoimmune diseases. Some people are born with intrinsic defects in their immune system, or primary immunodeficiency.A person who has an immunodeficiency of any kind is said to be immunocompromised. An immunocompromised individual may particularly be vulnerable to opportunistic infections, in addition to normal infections that could affect anyone. It also decreases cancer immunosurveillance, in which the immune system scans the body's cells and kills neoplastic ones.

Browse All Tags